2020
Press Releases
-
Early Introduction of Gluten May Prevent Celiac Disease in Children
-
Benaroya Research Institute at Virginia Mason Collaborates to Discover Genes that Block Viral Entry of Ebola and SARS Coronaviruses
-
GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases
-
Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason
-
Lynn Rose, PhD, to Retire from Benaroya Research Institute at Virginia Mason
-
Benaroya Research Institute at Virginia Mason Announces More Than $5.8M in NIH Funding for COVID-19 Research
-
Dr. Oliver Harrison Awarded First NOSTER Science Microbiome Prize for Winning Essay on T Cells and Tissue Repair
-
Benaroya Research Institute Launches Gut Research Program
-
Hamid Bolouri, PhD, named Associate Member in the Center for Systems Immunology at Benaroya Research Institute at Virginia Mason
-
Benaroya Research Institute Welcomes Four New Board Members
2019
Press Releases
-
Type 1 Diabetes Discovery Opens Door to Game-Changing Treatment Strategies
-
Benaroya Research Institute Receives $5.4 Million NIH Contract Award to Improve Treatment for Patients with Rheumatoid Arthritis
-
Benaroya Research Institute Opens the Sound Life Project, A Research Study of Healthy Immune Systems
-
Benaroya Research Institute Receives $4.5 Million Grant to Predict Which Cancer Patients will Benefit from Immunotherapy
-
Skin Immune Cell Discovery Challenges Beliefs About T Cells and How They Protect Against Infection
Early Introduction of Gluten May Prevent Celiac Disease in Children
Benaroya Research Institute at Virginia Mason Collaborates to Discover Genes that Block Viral Entry of Ebola and SARS Coronaviruses
GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases
Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason
Lynn Rose, PhD, to Retire from Benaroya Research Institute at Virginia Mason
Benaroya Research Institute at Virginia Mason Announces More Than $5.8M in NIH Funding for COVID-19 Research
Dr. Oliver Harrison Awarded First NOSTER Science Microbiome Prize for Winning Essay on T Cells and Tissue Repair
Benaroya Research Institute Launches Gut Research Program
Hamid Bolouri, PhD, named Associate Member in the Center for Systems Immunology at Benaroya Research Institute at Virginia Mason
Benaroya Research Institute Welcomes Four New Board Members
-
Type 1 Diabetes Discovery Opens Door to Game-Changing Treatment Strategies
-
Benaroya Research Institute Receives $5.4 Million NIH Contract Award to Improve Treatment for Patients with Rheumatoid Arthritis
-
Benaroya Research Institute Opens the Sound Life Project, A Research Study of Healthy Immune Systems
-
Benaroya Research Institute Receives $4.5 Million Grant to Predict Which Cancer Patients will Benefit from Immunotherapy
-
Skin Immune Cell Discovery Challenges Beliefs About T Cells and How They Protect Against Infection
